0001214659-21-001943.txt : 20210216 0001214659-21-001943.hdr.sgml : 20210216 20210216160129 ACCESSION NUMBER: 0001214659-21-001943 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20201231 FILED AS OF DATE: 20210216 DATE AS OF CHANGE: 20210216 EFFECTIVENESS DATE: 20210216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Octagon Capital Advisors LP CENTRAL INDEX KEY: 0001839435 IRS NUMBER: 843576791 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-20958 FILM NUMBER: 21637793 BUSINESS ADDRESS: STREET 1: 654 MADISON AVENUE STREET 2: 16TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 BUSINESS PHONE: 212-369-2829 MAIL ADDRESS: STREET 1: 654 MADISON AVENUE STREET 2: 16TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001839435 XXXXXXXX 12-31-2020 12-31-2020 false Octagon Capital Advisors LP
654 MADISON AVENUE 16TH FLOOR NEW YORK NY 10065
13F HOLDINGS REPORT 028-20958 N
Justin Hirsch Chief Compliance Officer and Chief Financial Officer 212-369-2829 /s/ Justin Hirsch New York NY 02-16-2021 0 31 288474
INFORMATION TABLE 2 infotable.xml 4D MOLECULAR THERAPEUTICS IN COM 35104E100 15659 377777 SH SOLE 377777 0 0 ACCELERON PHARMA INC COM 00434H108 14376 112363 SH SOLE 112363 0 0 ACLARIS THERAPEUTICS INC COM 00461U105 2265 350000 SH SOLE 350000 0 0 APELLIS PHARMACEUTICALS INC COM 03753U106 31367 548374 SH SOLE 548374 0 0 ARCUS BIOSCIENCES INC COM 03969F109 7788 300000 SH SOLE 300000 0 0 ARCUTIS BIOTHERAPEUTICS INC COM 03969K108 2813 100000 SH SOLE 100000 0 0 ARVINAS INC COM 04335A105 15160 178500 SH SOLE 178500 0 0 AVIDITY BIOSCIENCES INC COM 05370A108 10975 430041 SH SOLE 430041 0 0 AXSOME THERAPEUTICS INC COM 05464T104 1629 20000 SH SOLE 20000 0 0 CALLIDITAS THERAPEUTICS AB SPONSERED ADS 13124Q106 6724 200000 SH SOLE 200000 0 0 CARDIFF ONCOLOGY INC COM 14147L108 11694 650000 SH SOLE 650000 0 0 CELLDEX THERAPEUTICS INC NEW COM NEW 15117B202 18245 1041398 SH SOLE 1041398 0 0 CHEMOCENTRYX INC COM 16383L106 13937 225076 SH SOLE 225076 0 0 CURIS INC COM NEW 231269200 18018 2200000 SH SOLE 2200000 0 0 DYNE THERAPEUTICS INC COM 26818M108 10112 481538 SH SOLE 481538 0 0 FIBROGEN INC COM 31572Q808 5416 146014 SH SOLE 146014 0 0 GOSSAMER BIO INC COM 38341P102 15116 1563138 SH SOLE 1563138 0 0 HELIX ACQUISITION CORP COM CL A G4444C102 4548 400000 SH SOLE 400000 0 0 I MAB SPONSORED ADS 44975P103 21432 454550 SH SOLE 454550 0 0 INVENTIVA SA ADS 46124U107 2900 200000 SH SOLE 200000 0 0 IVERIC BIO INC COM 46583P102 4699 680036 SH SOLE 680036 0 0 JIYA ACQUISITION CORP COM CL A 47760M102 3090 300000 SH SOLE 300000 0 0 KADMON HLDGS INC COM 48283N106 1802 434114 SH SOLE 434114 0 0 KINIKSA PHARMACEUTICALS LTD COM CL A G5269C101 5217 295238 SH SOLE 295238 0 0 KRONOS BIO INC COM 50107A104 4366 146173 SH SOLE 146173 0 0 KURA ONCOLOGY INC COM 50127T109 4899 150000 SH SOLE 150000 0 0 NGM BIOPHARMACEUTICALS INC COM 62921N105 2279 75227 SH SOLE 75227 0 0 PMV PHARMACEUTICALS INC COM 69353Y103 15378 250000 SH SOLE 250000 0 0 REVOLUTION MEDICINES INC COM 76155X100 4994 126136 SH SOLE 126136 0 0 TAYSHA GENE THERAPIES INC COM SHS 877619106 8504 320440 SH SOLE 320440 0 0 VIELA BIO INC COM 926613100 3072 85409 SH SOLE 85409 0 0